1999
DOI: 10.1002/(sici)1097-0215(19990118)80:2<315::aid-ijc23>3.0.co;2-l
|View full text |Cite
|
Sign up to set email alerts
|

Angiogenesis inhibitors overcome tumor induced endothelial cell anergy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
59
0
1

Year Published

2002
2002
2017
2017

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 76 publications
(62 citation statements)
references
References 20 publications
2
59
0
1
Order By: Relevance
“…In recent years, ECs have been the target cell of some angiogenesis inhibitors that have been undergoing clinical trials. These inhibitors can selectively affect diverse EC functions that are related to angiogenesis, including activation, proliferation, migration, invasion and survival [25,26] . It has been reported that particles of realgar (As 2 S 2 ) with an average diameter of 100-150 nm can induce EVCV-304 cell apoptosis [27] .…”
Section: Discussionmentioning
confidence: 99%
“…In recent years, ECs have been the target cell of some angiogenesis inhibitors that have been undergoing clinical trials. These inhibitors can selectively affect diverse EC functions that are related to angiogenesis, including activation, proliferation, migration, invasion and survival [25,26] . It has been reported that particles of realgar (As 2 S 2 ) with an average diameter of 100-150 nm can induce EVCV-304 cell apoptosis [27] .…”
Section: Discussionmentioning
confidence: 99%
“…32 Reciprocally, ICAM-1 expression in melanoma cells and primary vascular endothelial cells could be completely suppressed and significantly overexpressed (59-fold and 135-fold, respectively). This is of particular importance, since ICAM-1 is specifically down-regulated in tumor endothelial cells during tumor angio-genesis 33 and de novo expression of ICAM-1 in melanoma correlates with increased risk of metastasis. 34 Therefore, our library and affinity maturation approach provide powerful TF ZF s to study ICAM-1 regulation and function by imposed regulation.…”
Section: Discussionmentioning
confidence: 99%
“…12 Comparative analysis of ICAM-1 flow cytometric data, mean fluorescence intensities (MFI), was determined using CELLQuest software (Becton Dickinson) as described. 33 For each sample analyzed, the MFI was corrected for background by subtraction of the autofluorescence of cells incubated with the secondary antibody only and normalized to the value of cells infected with the unselected 6ZFlibrary and presented as fold activation or percentage remaining ICAM-1. For ICAM-1 induction studies, 20 ng/ml IL-1b (Sigma) and 10 ng/ml TNF-a (Sigma) were added to the cells 12 hours before the FACS analysis.…”
Section: Retroviral Gene Delivery and Facsmentioning
confidence: 99%
“…Angiostatin, when bound to integrins, 35 may alter trafficking of lymphocytes, while the expression of hypoxic-induced proangiogenic factors in tumors can alter the expression of cell adhesion molecules involved in systemic cell trafficking. 36,37 Hence, this alteration by angiostatin in the trafficking of cells that have receptors for IL-2 may affect how IL-2 is distributed throughout the host. The significantly higher level of sFvIL-2 in the circulation and in the tumor may account for the improved efficacy of the coencapsulation protocol compared to the single IL-2 treatment (Fig 3b).…”
Section: Discussionmentioning
confidence: 99%